18175 Refining the Management of CMV in HCT Recipients: What Does the Future Hold?

In this activity, based on a recent symposium held at the 2018 BMT Tandem Meetings, experts discuss the clinical trends of cytomegalovirus (CMV) infection post-hematopoietic cell transplant (HCT) and map out the future of CMV management by analyzing the latest clinical evidence on novel approaches for prevention and treatment.

Target Audience

This activity has been designed to meet the educational needs of hematologist-oncologists, oncologists, BMT specialists and BMT nurse specialists, and other clinicians involved in the care of patients undergoing HCT.

Learning Objectives

  1. Discuss unmet needs associated with the management of CMV infection in HCT recipients
  2. Assess recent efficacy and safety data regarding novel approaches to prevent and treat CMV infection in the HCT setting
  3. Integrate expert recommendations and the results of recent clinical studies into strategies to prevent and treat CMV infection after HCT
Additional information

CME Coordinator Contact Information

Name: 
Michelle Stubley
Phone Number: 
+1 (414) 955-4900
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/22/2018
Course expires: 
02/21/2019
Cost:
$0.00

Francisco M. Marty, MD

Associate Professor of Medicine

Harvard Medical School

Division of Infectious Diseases

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Boston, Massachusetts

Kathleen Mullane, DO, PharmD, FIDSA

Professor, Department of Medicine

Section of Infectious Diseases

Director of Infectious Disease Clinical Trials

Immunocompromised Host Service

University of Chicago

Chicago, Illinois

All persons in control of content have no relevant financial relationships to disclose.

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and PeerView Institute for Medical Education. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
03/22/2018
Course expires: 
02/21/2019

Price

Cost:
$0.00
Please login or register to take this course.